APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI in Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI in Pharmaceutical Market Outlook and Growth Opportunities 2026

5 June 2026207 pages

Choose your research edition.

Industry ResearchAI in Pharmaceutical Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal AI in Pharmaceutical Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal AI in Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI in Pharmaceutical Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal AI in Pharmaceutical Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global AI in Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI in Pharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI in Pharmaceutical market include Cradle, Prezent, Insilico Medicine, Owkin, Inc, Certara, PathAI, Inc, Aizon, Salesforce, Inc and Aidoc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI in Pharmaceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI in Pharmaceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI in Pharmaceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI in Pharmaceutical market.

AI in Pharmaceutical Segment by Company

Cradle

Prezent

Insilico Medicine

Owkin, Inc

Certara

PathAI, Inc

Aizon

Salesforce, Inc

Aidoc

IQVIA

ISOMORPHIC LABS

ConcertAI

Nexocode

BenevolentAI

Recursion

Iktos

XtalPi Inc

AI in Pharmaceutical Segment by Type

Cloud-Based AI Solutions

On-Premises AI Platforms

AI in Pharmaceutical Segment by Application

Drug Discovery and Design

Biomarker Identification

Clinical Trial Optimization

Manufacturing Process Optimization

Others

AI in Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI in Pharmaceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI in Pharmaceutical key companies, revenue, market share, and recent developments.

3. To split the AI in Pharmaceutical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI in Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI in Pharmaceutical significant trends, drivers, influence factors in global and regions.

6. To analyze AI in Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI in Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI in Pharmaceutical industry.

Chapter 3: Detailed analysis of AI in Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI in Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI in Pharmaceutical Industry Trends Table 2. AI in Pharmaceutical Industry Drivers Table 3. AI in Pharmaceutical Industry Opportunities and Challenges Table 4. AI in Pharmaceutical Industry Restraints Table 5. Global AI in Pharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI in Pharmaceutical Revenue Share by Company (2021-2026) Table 7. Global AI in Pharmaceutical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI in Pharmaceutical Key Company Manufacturing Base & Headquarters Table 9. Global AI in Pharmaceutical Company, Product Type & Application Table 10. Global AI in Pharmaceutical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI in Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-Based AI Solutions Table 15. Significant Companies of On-Premises AI Platforms Table 16. Global AI in Pharmaceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI in Pharmaceutical Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI in Pharmaceutical Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI in Pharmaceutical Sales Value Share by Type (2021-2026) Table 20. Global AI in Pharmaceutical Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Drug Discovery and Design Table 22. Significant Companies of Biomarker Identification Table 23. Significant Companies of Clinical Trial Optimization Table 24. Significant Companies of Manufacturing Process Optimization Table 25. Significant Companies of Others Table 26. Global AI in Pharmaceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI in Pharmaceutical Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI in Pharmaceutical Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI in Pharmaceutical Sales Value Share by Application (2021-2026) Table 30. Global AI in Pharmaceutical Sales Value Share by Application (2027-2032) Table 31. Global AI in Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI in Pharmaceutical Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI in Pharmaceutical Sales Value Share by Region (2021-2026) Table 34. Global AI in Pharmaceutical Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI in Pharmaceutical Sales Value Share by Region (2027-2032) Table 36. Global AI in Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI in Pharmaceutical Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI in Pharmaceutical Sales Value Market Share by Country (2021-2026) Table 39. Global AI in Pharmaceutical Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI in Pharmaceutical Sales Value Market Share by Country (2027-2032) Table 41. Cradle Company Information Table 42. Cradle Business Overview Table 43. Cradle AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Cradle AI in Pharmaceutical Product Portfolio Table 45. Cradle Recent Development Table 46. Prezent Company Information Table 47. Prezent Business Overview Table 48. Prezent AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Prezent AI in Pharmaceutical Product Portfolio Table 50. Prezent Recent Development Table 51. Insilico Medicine Company Information Table 52. Insilico Medicine Business Overview Table 53. Insilico Medicine AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Insilico Medicine AI in Pharmaceutical Product Portfolio Table 55. Insilico Medicine Recent Development Table 56. Owkin, Inc Company Information Table 57. Owkin, Inc Business Overview Table 58. Owkin, Inc AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Owkin, Inc AI in Pharmaceutical Product Portfolio Table 60. Owkin, Inc Recent Development Table 61. Certara Company Information Table 62. Certara Business Overview Table 63. Certara AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Certara AI in Pharmaceutical Product Portfolio Table 65. Certara Recent Development Table 66. PathAI, Inc Company Information Table 67. PathAI, Inc Business Overview Table 68. PathAI, Inc AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PathAI, Inc AI in Pharmaceutical Product Portfolio Table 70. PathAI, Inc Recent Development Table 71. Aizon Company Information Table 72. Aizon Business Overview Table 73. Aizon AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Aizon AI in Pharmaceutical Product Portfolio Table 75. Aizon Recent Development Table 76. Salesforce, Inc Company Information Table 77. Salesforce, Inc Business Overview Table 78. Salesforce, Inc AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Salesforce, Inc AI in Pharmaceutical Product Portfolio Table 80. Salesforce, Inc Recent Development Table 81. Aidoc Company Information Table 82. Aidoc Business Overview Table 83. Aidoc AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Aidoc AI in Pharmaceutical Product Portfolio Table 85. Aidoc Recent Development Table 86. IQVIA Company Information Table 87. IQVIA Business Overview Table 88. IQVIA AI in Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. IQVIA AI in Pharmaceutical Product Portfolio Table 90. IQVIA Recent Development Table 91. ISOMORPHIC LABS Company Information Table 92. ISOMORPHIC LABS Business Overview Table 93. ISOMORPHIC LABS AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. ISOMORPHIC LABS AI in Pharmaceutical Product Portfolio Table 95. ISOMORPHIC LABS Recent Development Table 96. ConcertAI Company Information Table 97. ConcertAI Business Overview Table 98. ConcertAI AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. ConcertAI AI in Pharmaceutical Product Portfolio Table 100. ConcertAI Recent Development Table 101. Nexocode Company Information Table 102. Nexocode Business Overview Table 103. Nexocode AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Nexocode AI in Pharmaceutical Product Portfolio Table 105. Nexocode Recent Development Table 106. BenevolentAI Company Information Table 107. BenevolentAI Business Overview Table 108. BenevolentAI AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. BenevolentAI AI in Pharmaceutical Product Portfolio Table 110. BenevolentAI Recent Development Table 111. Recursion Company Information Table 112. Recursion Business Overview Table 113. Recursion AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Recursion AI in Pharmaceutical Product Portfolio Table 115. Recursion Recent Development Table 116. Iktos Company Information Table 117. Iktos Business Overview Table 118. Iktos AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Iktos AI in Pharmaceutical Product Portfolio Table 120. Iktos Recent Development Table 121. XtalPi Inc Company Information Table 122. XtalPi Inc Business Overview Table 123. XtalPi Inc AI in Pharmaceutical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. XtalPi Inc AI in Pharmaceutical Product Portfolio Table 125. XtalPi Inc Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. AI in Pharmaceutical Product Image Figure 2. Global AI in Pharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI in Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global AI in Pharmaceutical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-Based AI Solutions Image Figure 8. On-Premises AI Platforms Image Figure 9. Global AI in Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI in Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI in Pharmaceutical Sales Value Share by Type (2021-2032) Figure 12. Drug Discovery and Design Image Figure 13. Biomarker Identification Image Figure 14. Clinical Trial Optimization Image Figure 15. Manufacturing Process Optimization Image Figure 16. Others Image Figure 17. Global AI in Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI in Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI in Pharmaceutical Sales Value Share by Application (2021-2032) Figure 20. Global AI in Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI in Pharmaceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI in Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI in Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI in Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI in Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI in Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI in Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI in Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI in Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI in Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI in Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI in Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based AI Solutions
  • On-Premises AI Platforms
Applications
  • Drug Discovery and Design
  • Biomarker Identification
  • Clinical Trial Optimization
  • Manufacturing Process Optimization
  • Others
Companies covered
  • Cradle
  • Prezent
  • Insilico Medicine
  • Owkin, Inc
  • Certara
  • PathAI, Inc
  • Aizon
  • Salesforce, Inc
  • Aidoc
  • IQVIA
  • ISOMORPHIC LABS
  • ConcertAI
  • Nexocode
  • BenevolentAI
  • Recursion
  • Iktos
  • XtalPi Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI in Pharmaceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI in Pharmaceutical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI in Pharmaceutical Market Dynamics
  1. 2.1 AI in Pharmaceutical Industry Trends
  2. 2.2 AI in Pharmaceutical Industry Drivers
  3. 2.3 AI in Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 AI in Pharmaceutical Industry Restraints
3 AI in Pharmaceutical Market by Company
  1. 3.1 Global AI in Pharmaceutical Company Revenue Ranking in 2025
  2. 3.2 Global AI in Pharmaceutical Revenue by Company (2021-2026)
  3. 3.3 Global AI in Pharmaceutical Company Ranking (2024-2026)
  4. 3.4 Global AI in Pharmaceutical Company Manufacturing Base and Headquarters
  5. 3.5 Global AI in Pharmaceutical Company Product Type and Application
  6. 3.6 Global AI in Pharmaceutical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI in Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI in Pharmaceutical Market by Type
  1. 4.1 AI in Pharmaceutical Type Introduction
  2. 4.1.1 Cloud-Based AI Solutions
  3. 4.1.2 On-Premises AI Platforms
  4. 4.2 Global AI in Pharmaceutical Sales Value by Type
  5. 4.2.1 Global AI in Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI in Pharmaceutical Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI in Pharmaceutical Sales Value Share by Type (2021-2032)
5 AI in Pharmaceutical Market by Application
  1. 5.1 AI in Pharmaceutical Application Introduction
  2. 5.1.1 Drug Discovery and Design
  3. 5.1.2 Biomarker Identification
  4. 5.1.3 Clinical Trial Optimization
  5. 5.1.4 Manufacturing Process Optimization
  6. 5.1.5 Others
  7. 5.2 Global AI in Pharmaceutical Sales Value by Application
  8. 5.2.1 Global AI in Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global AI in Pharmaceutical Sales Value by Application (2021-2032)
  10. 5.2.3 Global AI in Pharmaceutical Sales Value Share by Application (2021-2032)
6 AI in Pharmaceutical Regional Value Analysis
  1. 6.1 Global AI in Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI in Pharmaceutical Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI in Pharmaceutical Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI in Pharmaceutical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI in Pharmaceutical Sales Value (2021-2032)
  7. 6.3.2 North America AI in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI in Pharmaceutical Sales Value (2021-2032)
  10. 6.4.2 Europe AI in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI in Pharmaceutical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI in Pharmaceutical Sales Value (2021-2032)
  16. 6.6.2 South America AI in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI in Pharmaceutical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 AI in Pharmaceutical Country-level Value Analysis
  1. 7.1 Global AI in Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI in Pharmaceutical Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI in Pharmaceutical Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI in Pharmaceutical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI in Pharmaceutical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cradle
  2. 8.1.1 Cradle Company Information
  3. 8.1.2 Cradle Business Overview
  4. 8.1.3 Cradle AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cradle AI in Pharmaceutical Product Portfolio
  6. 8.1.5 Cradle Recent Developments
  7. 8.2 Prezent
  8. 8.2.1 Prezent Company Information
  9. 8.2.2 Prezent Business Overview
  10. 8.2.3 Prezent AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Prezent AI in Pharmaceutical Product Portfolio
  12. 8.2.5 Prezent Recent Developments
  13. 8.3 Insilico Medicine
  14. 8.3.1 Insilico Medicine Company Information
  15. 8.3.2 Insilico Medicine Business Overview
  16. 8.3.3 Insilico Medicine AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Insilico Medicine AI in Pharmaceutical Product Portfolio
  18. 8.3.5 Insilico Medicine Recent Developments
  19. 8.4 Owkin, Inc
  20. 8.4.1 Owkin, Inc Company Information
  21. 8.4.2 Owkin, Inc Business Overview
  22. 8.4.3 Owkin, Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Owkin, Inc AI in Pharmaceutical Product Portfolio
  24. 8.4.5 Owkin, Inc Recent Developments
  25. 8.5 Certara
  26. 8.5.1 Certara Company Information
  27. 8.5.2 Certara Business Overview
  28. 8.5.3 Certara AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Certara AI in Pharmaceutical Product Portfolio
  30. 8.5.5 Certara Recent Developments
  31. 8.6 PathAI, Inc
  32. 8.6.1 PathAI, Inc Company Information
  33. 8.6.2 PathAI, Inc Business Overview
  34. 8.6.3 PathAI, Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PathAI, Inc AI in Pharmaceutical Product Portfolio
  36. 8.6.5 PathAI, Inc Recent Developments
  37. 8.7 Aizon
  38. 8.7.1 Aizon Company Information
  39. 8.7.2 Aizon Business Overview
  40. 8.7.3 Aizon AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aizon AI in Pharmaceutical Product Portfolio
  42. 8.7.5 Aizon Recent Developments
  43. 8.8 Salesforce, Inc
  44. 8.8.1 Salesforce, Inc Company Information
  45. 8.8.2 Salesforce, Inc Business Overview
  46. 8.8.3 Salesforce, Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Salesforce, Inc AI in Pharmaceutical Product Portfolio
  48. 8.8.5 Salesforce, Inc Recent Developments
  49. 8.9 Aidoc
  50. 8.9.1 Aidoc Company Information
  51. 8.9.2 Aidoc Business Overview
  52. 8.9.3 Aidoc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aidoc AI in Pharmaceutical Product Portfolio
  54. 8.9.5 Aidoc Recent Developments
  55. 8.10 IQVIA
  56. 8.10.1 IQVIA Company Information
  57. 8.10.2 IQVIA Business Overview
  58. 8.10.3 IQVIA AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IQVIA AI in Pharmaceutical Product Portfolio
  60. 8.10.5 IQVIA Recent Developments
  61. 8.11 ISOMORPHIC LABS
  62. 8.11.1 ISOMORPHIC LABS Company Information
  63. 8.11.2 ISOMORPHIC LABS Business Overview
  64. 8.11.3 ISOMORPHIC LABS AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ISOMORPHIC LABS AI in Pharmaceutical Product Portfolio
  66. 8.11.5 ISOMORPHIC LABS Recent Developments
  67. 8.12 ConcertAI
  68. 8.12.1 ConcertAI Company Information
  69. 8.12.2 ConcertAI Business Overview
  70. 8.12.3 ConcertAI AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ConcertAI AI in Pharmaceutical Product Portfolio
  72. 8.12.5 ConcertAI Recent Developments
  73. 8.13 Nexocode
  74. 8.13.1 Nexocode Company Information
  75. 8.13.2 Nexocode Business Overview
  76. 8.13.3 Nexocode AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nexocode AI in Pharmaceutical Product Portfolio
  78. 8.13.5 Nexocode Recent Developments
  79. 8.14 BenevolentAI
  80. 8.14.1 BenevolentAI Company Information
  81. 8.14.2 BenevolentAI Business Overview
  82. 8.14.3 BenevolentAI AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BenevolentAI AI in Pharmaceutical Product Portfolio
  84. 8.14.5 BenevolentAI Recent Developments
  85. 8.15 Recursion
  86. 8.15.1 Recursion Company Information
  87. 8.15.2 Recursion Business Overview
  88. 8.15.3 Recursion AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Recursion AI in Pharmaceutical Product Portfolio
  90. 8.15.5 Recursion Recent Developments
  91. 8.16 Iktos
  92. 8.16.1 Iktos Company Information
  93. 8.16.2 Iktos Business Overview
  94. 8.16.3 Iktos AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Iktos AI in Pharmaceutical Product Portfolio
  96. 8.16.5 Iktos Recent Developments
  97. 8.17 XtalPi Inc
  98. 8.17.1 XtalPi Inc Company Information
  99. 8.17.2 XtalPi Inc Business Overview
  100. 8.17.3 XtalPi Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  101. 8.17.4 XtalPi Inc AI in Pharmaceutical Product Portfolio
  102. 8.17.5 XtalPi Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst